MedPath

Magnesium chloride

Generic Name
Magnesium chloride
Brand Names
Bss, Bss Ophthalmic Solution, Cardioplegic, Chloromag, Citrasate, Clinimix E 2.75/5, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, H.E.L.P.bicel, Hemosate Ultra, Hyperlyte, Ionosol-MB, Isolyte P, Isolyte S, Isolyte S pH 7.4, Isoplate, Naturalyte, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Prismasol, Selectbag One
Drug Type
Small Molecule
Chemical Formula
Cl2Mg
CAS Number
7786-30-3
Unique Ingredient Identifier
59XN63C8VM

Overview

Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.

Background

Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.

Indication

Magnesium chloride is used in several medical and topical (skin related) applications. Magnesium chloride usp, anhydrous uses as electrolyte replenisher, pharmaceutic necessity for hemodialysis and peritoneal dialysis fluids.

Associated Conditions

  • Electrolyte imbalance
  • Magnesium Deficiency
  • Mild Metabolic acidosis

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Baxter Healthcare Company
0338-0210
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Baxter Healthcare Corporation
0338-0210
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Fresenius Medical Care North America
49230-212
INTRAPERITONEAL
5.08 mg in 100 mL
10/19/2023
Baxter Healthcare Corporation
24571-111
INTRAVENOUS
3.05 g in 1 L
11/1/2018
ICU Medical Inc.
0990-7372
INTRAVENOUS
30 mg in 100 mL
3/8/2021
Baxter Healthcare Company
0338-1147
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Baxter Healthcare Corporation
0338-1147
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Baxter Healthcare Company
0338-1142
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Baxter Healthcare Corporation
0338-1142
INTRAVENOUS
51 mg in 100 mL
9/21/2020
Baxter Healthcare Corporation
0941-0433
INTRAPERITONEAL
5.08 mg in 100 mL
11/21/2019

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
OLICLINOMEL N4-550 E EMULSION FOR INFUSION
SIN12542P
EMULSION
0.45 g/l
5/6/2004
BALANCE 1.5% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 17 FORMULATION)
SIN13265P
SOLUTION, STERILE
0.1017 G/L
5/2/2007
HAEMODIALYSIS CONCENTRATE NKFS-02 (ACID) FOR BICARBONATE DIALYSIS
SIN07943P
SOLUTION
3.58 g/l
12/1/1994
DIANEAL PD-2 PERITONEAL DIALYSIS SOLUTION WITH 4.25% DEXTROSE
SIN05589P
SOLUTION, STERILE
5.08 mg/100 ml
3/27/1991
PLASMA-LYTE A INJECTION
SIN06523P
INJECTION
30 mg/100 ml
8/19/1991
EXTRANEAL PERITONEAL DIALYSIS SOLUTION 75 g/l
SIN11220P
SOLUTION, STERILE
50.8 mg/l
11/9/1999
EUROPERSOL WITH DEXTROSE 4.25% PERITONEAL DIALYSIS SOLUTION
SIN10271P
SOLUTION, STERILE
15.2 mg/100 ml
10/14/1998
BALANCE 4.25% GLUCOSE 1.25 MMOL/L CALCIUM PERITONEAL DIALYSIS SOLUTION (CAPD 18 FORMULATION)
SIN13264P
SOLUTION, STERILE
0.1017 G/L
5/2/2007
DUOSOL WITH 4 MMOL/L POTASSIUM SOLUTION FOR HAEMOFILTRATION
SIN15785P
SOLUTION, STERILE
0.91g/1000ml
8/20/2019
DIANEAL LOW CALCIUM (2.5 mEq/l) PERITONEAL DIALYSIS SOLUTION WITH 4.25% DEXTROSE
SIN06625P
SOLUTION, STERILE
5.08 mg/100 ml
10/14/1991

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath